FDA PCAC reviews 7 peptides in July. Read →

PeptideXpo

Retatrutide

GIP / GLP-1 / glucagon tri-agonist

≥ 99.0%CAS 2381089-83-2Metabolic & GLP-1

Overview

Retatrutide is an investigational tri-agonist peptide targeting GIP, GLP-1, and glucagon receptors. PeptideXpo supplies high-purity Retatrutide for compounding pharmacy and research applications under research-use-only terms.

Specifications

CAS
2381089-83-2
Appearance
White lyophilized powder
Purity (HPLC)
≥ 99.0%
Common vial sizes
5 mg, 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg
MOQ
On request
Lead time
10–18 days
Storage
-20°C, protect from light

Documentation available on request

  • Certificate of Analysis (COA)
  • HPLC Chromatogram
  • Mass-spec spectrum
  • Stability data
  • SDS / MSDS
  • Sequence verification